| Specialty Retail Industry | Consumer Discretionary Sector | Mr. S. Venkatesh CEO | MSE Exchange | INE540L01014 ISIN |
| India Country | 17,432 Employees | 7 Aug 2026 Last Dividend | - Last Split | - IPO Date |
Alkem Laboratories Limited stands as a notable entity in the pharmaceutical sector, with its core operations involving research and development, manufacturing, and the sale of pharmaceutical and nutraceutical products. The company, which finds its roots in India, has established a strong presence both locally and internationally, including in the United States. Since its inception in 1973, Alkem Laboratories has carved a niche in delivering high-quality healthcare products, underpinned by its headquarters located in Mumbai, India. It has successfully navigated the intricate landscape of the pharmaceutical industry to become a significant player known for its diversified range of products that address a spectrum of therapeutic areas.
Alkem Laboratories Limited offers a wide array of products and services spanning various therapeutic categories and healthcare needs: